Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Rizzolio

Showing results (31-40 of 159) with videos related to

Pageof 16
Sort By:
Biomaterials Science|March 18, 2025
Self-targeted nanosystem for enhanced chemodynamic cancer therapyKanwal Asif, Md Mahbubur Rahman, Vincenzo Canzonieri, et al.
Current Topics in Medicinal Chemistry|April 8, 2010
Adenosine receptor ligands in clinical trialsFlavio Rizzolio, Raffaele La Montagna, Tiziano Tuccinardi, et al.
Nanoscale Advances|September 22, 2022
Carbon dots for cancer nanomedicine: a bright futureSamer Bayda, Emanuele Amadio, Simone Cailotto, et al.
Biosensors & Bioelectronics|July 31, 2020
Recent advances of electrochemical and optical enzyme-free glucose sensors operating at physiological conditionsMuhammad Adeel, Md Mahbubur Rahman, Isabella Caligiuri, et al.
Nanomedicine (London, England)|August 26, 2016
Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse modelsMohamad Hadla, Stefano Palazzolo, Giuseppe Corona, et al.
Dalton Transactions (Cambridge, England : 2003)|December 8, 2025
Palladium(0) and Juglone: a new alliance in the fight against ovarian cancerGiovanni Tonon, Anna Rafaniello, Matteo Mauceri, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2018
Rational Development of MAGL InhibitorsCarlotta Granchi, Flavio Rizzolio, Isabella Caligiuri, et al.
Current Medicinal Chemistry|December 30, 2017
Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to ClinicSamer Bayda, Mohamad Hadla, Stefano Palazzolo, et al.
Expert Opinion on Therapeutic Patents|October 21, 2020
An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)Giulia Bononi, Giulio Poli, Flavio Rizzolio, et al.
Molecules (Basel, Switzerland)|March 13, 2024
Platinum(0)-η<sup>2</sup>-1,2-(<i>E</i>)ditosylethene Complexes Bearing Phosphine, Isocyanide and <i>N</i>-Heterocyclic Carbene Ligands: Synthesis and Cytotoxicity towards Ovarian and Breast Cancer CellsNicola Compagno, Rachele Piccolo, Enrica Bortolamiol, et al.
Pageof 16

Showing results (31-40 of 159) with videos related to

Sort By:
Pageof 16
Biomaterials Science|March 18, 2025
Self-targeted nanosystem for enhanced chemodynamic cancer therapyKanwal Asif, Md Mahbubur Rahman, Vincenzo Canzonieri, et al.
Current Topics in Medicinal Chemistry|April 8, 2010
Adenosine receptor ligands in clinical trialsFlavio Rizzolio, Raffaele La Montagna, Tiziano Tuccinardi, et al.
Nanoscale Advances|September 22, 2022
Carbon dots for cancer nanomedicine: a bright futureSamer Bayda, Emanuele Amadio, Simone Cailotto, et al.
Biosensors & Bioelectronics|July 31, 2020
Recent advances of electrochemical and optical enzyme-free glucose sensors operating at physiological conditionsMuhammad Adeel, Md Mahbubur Rahman, Isabella Caligiuri, et al.
Nanomedicine (London, England)|August 26, 2016
Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse modelsMohamad Hadla, Stefano Palazzolo, Giuseppe Corona, et al.
Dalton Transactions (Cambridge, England : 2003)|December 8, 2025
Palladium(0) and Juglone: a new alliance in the fight against ovarian cancerGiovanni Tonon, Anna Rafaniello, Matteo Mauceri, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2018
Rational Development of MAGL InhibitorsCarlotta Granchi, Flavio Rizzolio, Isabella Caligiuri, et al.
Current Medicinal Chemistry|December 30, 2017
Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to ClinicSamer Bayda, Mohamad Hadla, Stefano Palazzolo, et al.
Expert Opinion on Therapeutic Patents|October 21, 2020
An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)Giulia Bononi, Giulio Poli, Flavio Rizzolio, et al.
Molecules (Basel, Switzerland)|March 13, 2024
Platinum(0)-η<sup>2</sup>-1,2-(<i>E</i>)ditosylethene Complexes Bearing Phosphine, Isocyanide and <i>N</i>-Heterocyclic Carbene Ligands: Synthesis and Cytotoxicity towards Ovarian and Breast Cancer CellsNicola Compagno, Rachele Piccolo, Enrica Bortolamiol, et al.
Pageof 16